Dood Kooban oo ku saabsan Cilmi-baarista Ashwagandha

Daraasad caafimaad oo cusub oo aadanaha laga sameeyay ayaa adeegsatay soosaar tayo sare leh oo shati leh, Witholytin, si loo qiimeeyo saameynta wanaagsan ee uu ku leeyahay daalka iyo walbahaarka.
Cilmi-baarayaashu waxay qiimeeyeen badbaadada ashwagandha iyo saameynta ay ku leedahay daalka iyo walbahaarka la dareemayo ee 111 rag iyo dumar caafimaad qaba oo da'doodu u dhaxayso 40-75 sano kuwaas oo la kulmay heerarka tamarta oo hooseeya iyo walbahaarka la dareemayo ee dhexdhexaad ah ilaa sare muddo 12 toddobaad ah. Daraasaddu waxay isticmaashay qiyaas dhan 200 mg oo ashwagandha ah laba jeer maalintii.
Natiijooyinku waxay muujiyeen in ka qaybgalayaasha qaadanaya ashwagandha ay la kulmeen hoos u dhac weyn oo 45.81% ah oo ku yimid dhibcaha Chalder Fatigue Scale (CFS) ee caalamiga ah iyo hoos u dhac 38.59% ah oo ku yimid walbahaarka (cabirka walbahaarka ee la dareemayo) marka loo eego asalka 12 toddobaad ka dib.
Natiijooyin kale ayaa muujiyay in dhibcaha jirka ee Nidaamka Macluumaadka Cabbirka Natiijada Bukaanka ee la soo sheegay (PROMIS-29) ay kordheen (hagaajiyeen) 11.41%, dhibcaha cilminafsiga ee PROMIS-29 (hagaajiyeen) ay hoos u dhaceen 26.30% waxayna kordheen 9.1% marka la barbar dhigo placebo. Kala duwanaanshaha garaaca wadnaha (HRV) ayaa hoos u dhacay 18.8%.
Gunaanadka daraasaddan ayaa muujinaya in ashwagandha ay leedahay awood ay ku taageerto hab-dhaqan la qabsi, la dagaallanto daalka, dib u soo noolaynta, iyo kor u qaadida homeostasis iyo dheelitirka.
Cilmi-baarayaasha ku lug lahaa daraasadda ayaa sheegaya in ashwagandha ay leedahay faa'iidooyin firfircoon oo muhiim ah oo loogu talagalay dadka da'da dhexe iyo kuwa da'da weyn ee cayilan ee la kulma heerarka sare ee walbahaarka iyo daalka.
Falanqayn hoose ayaa la sameeyay si loo baaro astaamaha hormoonnada ee ka qaybgalayaasha ragga iyo dumarka. Heerarka dhiigga ee testosterone-ka bilaashka ah (p = 0.048) iyo hoormoonka luteinizing (p = 0.002) ayaa si weyn u kordhay 12.87% ragga qaadanaya ashwagandha marka la barbar dhigo kooxda placebo.
Marka la eego natiijooyinkan, waxaa muhiim ah in si dheeraad ah loo barto kooxaha dadka ee ka faa'iideysan kara qaadashada ashwagandha, maadaama saameynteeda yareynta walbahaarka ay kala duwanaan karto iyadoo ku xiran arrimo ay ka mid yihiin da'da, jinsiga, heerka tusmada cufnaanta jirka, iyo doorsoomayaal kale.
"Waxaan ku faraxsanahay in daabacaaddan cusub ay isku darayso caddaynta taageeraysa Vitolitin iyo caddaymaheenna sii kordhaya ee muujinaya heerka USP ee soosaarka ashwagandha," ayay sharraxday Sonya Cropper, madaxweyne ku xigeenka fulinta ee Verdure Sciences. Cropper ayaa sii wadata, "Waxaa sii kordhaya xiisaha loo qabo ashwagandha, adaptogens, daalka, tamarta iyo waxqabadka maskaxda."
Vitolitin waxaa soo saarta Verdure Sciences waxaana Yurub ku qaybiya LEHVOSS Nutrition, oo ah qayb ka mid ah Kooxda LEHVOSS.


Waqtiga boostada: Febraayo-13-2024